Pfizer move means Sangamo won’t receive an expected payout in the first quarter, creating a cash overhang.
Source link
Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends hemophilia pact
-
Neclink.com
- . December 31, 2024
